Comparison between 20G and 22G for amniocentesis complications
Not Applicable
- Conditions
- Detect of chromosal abnormalities.??????? ????????? ? ????????
- Registration Number
- IRCT201510037676N3
- Lead Sponsor
- Vice chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
single pregnancy;no history of cervical classic failure,hereditary or non-hereditary coagulation disorders, myoma,major fetal anomalies.
Exclusion criterion: withdrew from continuing the research
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain intencity. Timepoint: During amniocentesis. Method of measurement: VAS (Visual Analog Scale) system.
- Secondary Outcome Measures
Name Time Method Abortion under 22 weeks. Timepoint: Up to a week after amniocentesis. Method of measurement: During the phone call.The symptoms of bleeding and pain and miscarriage.;Vaginal bleeding. Timepoint: Up to a week after amniocentesis. Method of measurement: 1-Less than menstrual bleeding 2-menstrual bleedingl.3- more than menstrual bleeding.;Continuous leakage of amniotic fluid. Timepoint: After 6 hours of amniocentesis to 1 week after the procedure. Method of measurement: Observation, ultrasound , nitrazine test.;Chorioamnionitis. Timepoint: Until a week after the procedure. Method of measurement: Uterine tenderness and maternal fever greater than 38°C.;Uterine cramps. Timepoint: After 6 hours of amniocentesis to 1 week after the procedure. Method of measurement: Uterine contractions felt by the patient.